secwatch.observer — SEC 8-K summary
======================================

Issuer:     TherapeuticsMD, Inc. (TXMD)
CIK:        0000025743
Form:       8-K
Filed at:   2021-10-01T23:59:59+00:00
Accession:  0001564590-21-049852
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

TherapeuticsMD EVP Operations Edward Borkowski departs effective Sept 30, 2021
------------------------------------------------------------------------------

- Mr. Borkowski and company mutually agreed to separation; departure effective September 30, 2021.
- Separation treated as 'Good Reason' under Oct 2019 employment agreement; eligible for contractual severance benefits.
- No successor named; responsibilities reassigned among remaining executives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/25743/000156459021049852/0001564590-21-049852-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/25743/000156459021049852/txmd-8k_20210930.htm
  HTML page:      https://secwatch.observer/filing/0001564590-21-049852

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer